Pharmac is seeking public feedback on a proposal to fund a new, additional type of insulin for people with diabetes from 1 May 2025. The new medicine (branded as Ryzodeg) is a combination of two other ...
NovoRapid revenues increased 62% and Human insulin revenues increased 11%. Premix insulin (Ryzodeg and NovoMix) revenues grew 33% year over year. Sales of long-acting insulins (Tresiba ...
Groundbreaking research has been presented at this year's Diabetes UK Professional Conference 2025, including a study into worsening inequalities in type 1 diabetes outcomes, and research into how AI ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback